Research keywords (3)：
NKG2D ligands
, cancer immunotherapy
, lung cancer
Research theme for competitive and other funds (4)：
2020 - 2024 非結核性抗酸菌症と腸内細菌叢の関わりについて
2017 - 2020 Therapeutic strategies targeting mTOR and FAK for squamous cell lung cancer
2014 - 2018 Development of the new clinical cure to overcome pemetrexed tolerance for malignant pleural mesothelioma
2014 - 2018 A novel therapy for sepsis by regulating soluble ULBP2
Papers (66)：
Genki Inui, Yoshihiro Funaki, Haruhiko Makino, Hirokazu Touge, Katsunori Arai, Keisuke Kuroda, Yuuki Hirayama, Ryohei Kato, Takafumi Nonaka, Kohei Yamane, et al. Pembrolizumab-induced aseptic meningitis in a patient with non-small cell lung cancer: A case report and literature review of aseptic meningitis as an immune-related adverse event. Molecular and clinical oncology. 2022. 17. 1. 120-120
石川博基, 舟木佳弘, 阪本智宏, 高田美樹, 木下直樹, 山口耕介, 森田正人, 小谷昌広, 夕永裕士, 山崎章. A study of Amrubicin for lung cancer with interstitial lung abnormality. 日本呼吸器学会誌(Web). 2021. 10
